These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16964195)

  • 1. Companies eye slice of age-related macular degeneration market.
    Waltz E
    Nat Biotechnol; 2006 Sep; 24(9):1041-2. PubMed ID: 16964195
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 3. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 4. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 5. Maturing biotechs turn to pharma's markets.
    Ratner M
    Nat Biotechnol; 2005 Mar; 23(3):269. PubMed ID: 15765067
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 7. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI; Rabinovich ML
    Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market watch: Biopharma deal-making in 2014: a record year for M&A value.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786
    [No Abstract]   [Full Text] [Related]  

  • 9. Designs that enrich lives.
    Link A; Stark H
    Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676
    [No Abstract]   [Full Text] [Related]  

  • 10. Roche consolidates grip on anti-angiogenesis market.
    Moran N
    Nat Biotechnol; 2008 Oct; 26(10):1055-6. PubMed ID: 18846054
    [No Abstract]   [Full Text] [Related]  

  • 11. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 12. Should platform companies move toward products?
    Ratner M
    Nat Biotechnol; 1999 Jan; 17(1):16-7. PubMed ID: 9920255
    [No Abstract]   [Full Text] [Related]  

  • 13. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 14. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 16. Regeneron focuses on age-related macular degeneration.
    Wolfson W
    Chem Biol; 2008 Apr; 15(4):303-4. PubMed ID: 18420133
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemist strikes gold.
    Wadman M
    Nature; 2006 Jun; 441(7094):689. PubMed ID: 16760950
    [No Abstract]   [Full Text] [Related]  

  • 18. Stats. Sticking with growth. Vaccine market continues to rise.
    Martineau B
    Mater Manag Health Care; 2004 Nov; 13(11):42. PubMed ID: 15603109
    [No Abstract]   [Full Text] [Related]  

  • 19. More than meets the eyes?
    Jacobs T
    Nat Biotechnol; 2004 Oct; 22(10):1221. PubMed ID: 15470455
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech drugs come of age; policymakers take notice.
    Iglehart JK
    Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.